Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy.
Cancer prevention
Cancer survivorship
Colorectal cancer
Gastroenterology
Oncology
Journal
Clinical colorectal cancer
ISSN: 1938-0674
Titre abrégé: Clin Colorectal Cancer
Pays: United States
ID NLM: 101120693
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
24
06
2023
revised:
17
07
2023
accepted:
02
08
2023
medline:
4
12
2023
pubmed:
17
8
2023
entrez:
16
8
2023
Statut:
ppublish
Résumé
Survival rates in early-stage rectal cancer patients have increased over the past few decades. Societies such as the National Comprehensive Cancer Network (NCCN), American Cancer Society (ACS), American Society of Clinical Oncology (ASCO), and European Society of Medical Oncology (ESMO) have proposed guidelines related to cancer survivorship care including formal recommendations to address the needs in early-stage rectal cancer survivors. These guidelines, in addition to new clinical research findings in survivorship will be reviewed, specifically looking at physical, psychosocial, and financial concerns in rectal cancer survivorship.
Identifiants
pubmed: 37586927
pii: S1533-0028(23)00066-X
doi: 10.1016/j.clcc.2023.08.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
375-382Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have stated that they have no conflicts of interest.